Dysregulated skin barrier function in Tmem79 mutant mice promotes IL‐17A‐dependent spontaneous skin and lung inflammation
Open Access
Abstract
Background: Atopic dermatitis (AD) is associated with a dysregulation of the skin barrier and may predispose to the development of secondary allergic conditions, such as asthma. Tmem79ma/ma mice harbor a mutation in the gene encoding Transmembrane Protein 79 (or Mattrin), which has previously been associated with AD. As a result of the Tmem79 gene mutation, these mice have a defective skin barrier and develop spontaneous skin inflammation. In this study, Tmem79ma/ma mice were assessed for the underlying immunological response in the development of spontaneous skin and lung inflammation.Methods: Development of spontaneous skin and lung inflammation in Tmem79ma/ma mice was analyzed. We further investigated susceptibility to cutaneous Staphylococcus aureus infection. Tmem79ma/ma were crossed to IL‐17A‐deficient mice to address the contribution of IL‐17A to spontaneous skin and lung disease.Results: Tmem79ma/ma mice developed IL‐17A‐dependent spontaneous AD‐like inflammation and were refractory to S aureus infection. Mutant mice progressed to airway inflammation subsequent to the occurrence of dermatitis. The progression from skin to lung disease is dependent on adaptive immunity and is facilitated by cutaneous expansion of Th17 and TCRγδ T cells.Conclusion: Mice lacking Tmem79/Mattrin expression have a defective skin barrier. In adulthood, these mice develop dermatitis with secondary progression to lung inflammation. The development of skin and lung inflammation is IL‐17A‐dependent and mediated by TCRγδ T cells.Keywords
Funding Information
- Irish Research Council
- European Molecular Biology Organization (ALTF 587‐2016)
- National Children's Research Centre
- Else Kröner-Fresenius-Stiftung (2019_A181)
- Science Foundation Ireland (10/IN.1/B3004)
This publication has 44 references indexed in Scilit:
- Expression of IL-22 in the Skin Causes Th2-Biased Immunity, Epidermal Barrier Dysfunction, and Pruritus via Stimulating Epithelial Th2 Cytokines and the GRP PathwayThe Journal of Immunology, 2017
- Multifactorial skin barrier deficiency and atopic dermatitis: Essential topics to prevent the atopic marchJournal of Allergy and Clinical Immunology, 2016
- Global Allergy Forum and 3rd Davos Declaration 2015Allergy, 2016
- Atopic dermatitisThe Lancet, 2016
- IL-17A as an Inducer for Th2 Immune Responses in Murine Atopic Dermatitis ModelsJournal of Investigative Dermatology, 2014
- Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitisJournal of Allergy and Clinical Immunology, 2013
- Progressive activation of TH2/TH22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitisJournal of Allergy and Clinical Immunology, 2012
- From atopic dermatitis to asthma: the atopic marchAnnals of Allergy, Asthma & Immunology, 2010
- “Outside-to-Inside” (and Now Back to “Outside”) Pathogenic Mechanisms in Atopic DermatitisJournal of Investigative Dermatology, 2008
- Atopic DermatitisNew England Journal of Medicine, 2008